Rare but Serious Risks: Identifying Red Flags While the vast majority of patients successfully manage mild gastrointestinal adjustments, your safety depends on recognizing rare but significant clinical signals
Nutritional Risks of Combining Fasting and GLP-1 Therapy The biggest risk when merging intermittent fasting with GLP-1 use is consuming too few calories during eating windows, leading to protein deficiency, micronutrient gaps, and loss of lean muscle mass
A reality check Four Corners gave Rachel's treatment plan to endocrinologist Katherine Samaras to review
Join Trial Testing New Drug for Weight Management A clinical trial is recruiting adults with type 2 diabetes to test a new long-lasting amylin drug for weight management
It works by mimicking a natural hormone in the body called GLP-1, which helps regulate insulin release, reduces appetite, and slows down the emptying of the stomach after eating
Research shows that luteolin can inhibit the production of ROS by regulating neutrophils, a process aided by the suppression of Raf1 activity (109)